Home » Stocks » GTHP

Guided Therapeutics, Inc. (GTHP)

Stock Price: $0.443 USD 0.000 (0.00%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
Market Cap 6.29M
Revenue (ttm) 93,000
Net Income (ttm) n/a
Shares Out 13.14M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $0.443
Previous Close $0.443
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.500
Day's Range 0.420 - 0.525
Day's Volume 16,680
52-Week Range -

News

There are no news available yet.

About GTHP

Guided Therapeutics, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is ba... [Read more...]

Industry
Medical Devices
IPO Date
Jul 1, 1997
CEO
Gene Cartwright
Employees
5
Stock Exchange
OTCMKTS
Ticker Symbol
GTHP
Full Company Profile